Amgen: Accelerating The Business & Dividend Growth (NASDAQ:AMGN)

[ad_1]

Biology laboratory nature and science, Plants with biochemistry structure on green background.

ipopba

Amgen Inc. (NASDAQ:AMGN) has an impressive total return and dividend growth track record with a solid financial foundation, but faces operational challenges under the burden of significant investment. While this could undermine its dividend growth performance long term, I believe

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *